Invention Grant
- Patent Title: Furopyridine compounds for the treatment of hepatitis C
-
Application No.: US15500110Application Date: 2015-08-04
-
Publication No.: US09957278B2Publication Date: 2018-05-01
- Inventor: Tao Wang , Kyle J. Eastman , Zhongxing Zhang , Kyle E. Parcella , John F. Kadow
- Applicant: BRISTOL-MYERS SQUIBB COMPANY
- Applicant Address: US NJ Princeton
- Assignee: Bristol-Myers Squibb Company
- Current Assignee: Bristol-Myers Squibb Company
- Current Assignee Address: US NJ Princeton
- Agent James Epperson
- International Application: PCT/US2015/043522 WO 20150804
- International Announcement: WO2016/022513 WO 20160211
- Main IPC: C07D491/048
- IPC: C07D491/048 ; A61K31/4355 ; C07B59/00
Abstract:
Compounds of formula I, including their salts, as well as compositions and methods of using the compounds are set forth. The compounds have activity against hepatitis C virus (HCV) and may be useful in treating those infected with HCV.
Public/Granted literature
- US20170247385A1 FUROPYRIDINE COMPOUNDS FOR THE TREATMENT OF HEPATITIS C Public/Granted day:2017-08-31
Information query
